Multicenter open label study to determine the dose and safety of oral asciminib in pediatric patients with Ph CHROMOSOME POSİTİVE CHRONİC MYELOİD LEUKEMİA İN CHRONİC PHASE previously treated with one or more tyrosine kinase inhibitors
Karakaş Z. (Executive), Tanyıldız H. G.
Other International Funding Programs, 2021 - 2023
-
Project Type:
Other International Funding Programs
-
Begin Date:
August 2021
-
End Date:
August 2023